Jiancang Ma

669 total citations
28 papers, 463 citations indexed

About

Jiancang Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiancang Ma has authored 28 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jiancang Ma's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (3 papers). Jiancang Ma is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (3 papers). Jiancang Ma collaborates with scholars based in China and United States. Jiancang Ma's co-authors include Qinghua Su, Tao Shan, Xijuan Cui, Ya’an Kang, Xin Huang, Yiming Li, Hong Ji, Shuo Chen, Xi Chen and Tao Wu and has published in prestigious journals such as Life Sciences, Journal of Cellular Physiology and International Journal of Biological Macromolecules.

In The Last Decade

Jiancang Ma

27 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiancang Ma China 11 278 200 126 102 48 28 463
Chengkun Qin China 16 336 1.2× 242 1.2× 174 1.4× 66 0.6× 80 1.7× 35 559
Xiaohong Shen China 16 365 1.3× 154 0.8× 263 2.1× 123 1.2× 46 1.0× 25 647
Chuanyong Zhang China 13 382 1.4× 231 1.2× 156 1.2× 125 1.2× 57 1.2× 25 630
Nanhong Tang China 11 211 0.8× 173 0.9× 102 0.8× 80 0.8× 68 1.4× 18 391
Pan Liu China 15 354 1.3× 233 1.2× 105 0.8× 65 0.6× 51 1.1× 32 554
Benjamin L. Emmink Netherlands 10 281 1.0× 114 0.6× 131 1.0× 86 0.8× 89 1.9× 23 496
Shenghui Qin China 12 297 1.1× 156 0.8× 108 0.9× 56 0.5× 31 0.6× 27 476
Eunsun Jung South Korea 13 228 0.8× 102 0.5× 110 0.9× 79 0.8× 82 1.7× 40 504
Beibei Liu China 13 477 1.7× 225 1.1× 164 1.3× 65 0.6× 39 0.8× 46 711

Countries citing papers authored by Jiancang Ma

Since Specialization
Citations

This map shows the geographic impact of Jiancang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiancang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiancang Ma more than expected).

Fields of papers citing papers by Jiancang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiancang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiancang Ma. The network helps show where Jiancang Ma may publish in the future.

Co-authorship network of co-authors of Jiancang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jiancang Ma. A scholar is included among the top collaborators of Jiancang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiancang Ma. Jiancang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ma, Jiancang, et al.. (2024). Downregulation of lncRNA EPB41L4A-AS1 promotes gastric cancer cell proliferation, migration and invasion. BMC Gastroenterology. 24(1). 136–136. 2 indexed citations
4.
5.
Ma, Jiancang, et al.. (2023). SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway. Molecular Medicine. 29(1). 121–121. 5 indexed citations
6.
Shu, Jian, Junhong Wang, Yonghong Guo, et al.. (2022). Machine learning reveals salivary glycopatterns as potential biomarkers for the diagnosis and prognosis of papillary thyroid cancer. International Journal of Biological Macromolecules. 215. 280–289. 21 indexed citations
7.
Huang, Xin, et al.. (2020). Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis. Life Sciences. 264. 118622–118622. 27 indexed citations
8.
9.
Chen, Shuo, Meng Xu, Jiaqi Shen, et al.. (2020). MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1. International Journal of Biological Sciences. 16(12). 2159–2169. 22 indexed citations
10.
Shan, Tao, Shuo Chen, Xi Chen, et al.. (2019). Association of family history of tumors with clinicopathological characteristics and prognosis of colorectal cancer. European Journal of Cancer Prevention. 28(4). 258–267. 5 indexed citations
11.
Chen, Shuo, Tao Shan, Xi Chen, et al.. (2019). Association of treRNA with lymphatic metastasis and poor prognosis in colorectal cancer.. PubMed. 12(5). 1770–1774. 2 indexed citations
12.
Shan, Tao, Shuo Chen, Xi Chen, et al.. (2017). Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism. Oncology Reports. 37(4). 1971–1979. 91 indexed citations
13.
Su, Qinghua, et al.. (2017). TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway. Oncology Reports. 37(3). 1555–1564. 47 indexed citations
14.
Huang, Xin, et al.. (2016). miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway. International Journal of Oncology. 49(4). 1629–1637. 14 indexed citations
15.
Su, Qinghua, et al.. (2016). Embryonic develop-associated gene 1 is overexpressed and acts as a tumor promoter in thyroid carcinoma. Biomedicine & Pharmacotherapy. 81. 86–92. 2 indexed citations
16.
Shan, Tao, Shuo Chen, Xi Chen, et al.. (2016). Prometastatic mechanisms of CAF-mediated EMT regulation in pancreatic cancer cells. International Journal of Oncology. 50(1). 121–128. 36 indexed citations
17.
Huang, Xin, et al.. (2014). Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression. Molecular Medicine Reports. 11(3). 2334–2340. 20 indexed citations
18.
Liu, Yang, Yiming Li, Jiancang Ma, Le Lü, & Li Zhang. (2013). A modified Hassab’s operation for portal hypertension: experience with 562 cases. Journal of Surgical Research. 185(1). 463–468. 8 indexed citations
19.
Ma, Jiancang. (2007). Research on Tilt and Environment Error Compensation of Electronic Compass. Chuangan jishu xuebao. 6 indexed citations
20.
Feng, Yan, Jun Zhao, Jiancang Ma, Zongfang Li, & Qinghua Su. (2003). Metabolic effects of a novel bioartificial liver on serum from severe hepatitis patients: an in vitro study.. PubMed. 116(10). 1471–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengkun Qin Breakdown of academic impact, for papers by Xiaohong Shen Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Nanhong Tang Breakdown of academic impact, for papers by Pan Liu Breakdown of academic impact, for papers by Benjamin L. Emmink Breakdown of academic impact, for papers by Shenghui Qin Breakdown of academic impact, for papers by Eunsun Jung Breakdown of academic impact, for papers by Beibei Liu
Rankless by CCL
2026